Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT01370876 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped company policy

Conditions

Cancer of the Head and Neck
Neoplasms, Head and Neck

Interventions

DRUG: Oxaliplatin

Sponsor

Nang Kuang Pharmaceutical Co., Ltd.